Smaller, more frequent meals, typically four to six per day, often work better than two or three large meals
Semaglutide and liraglutide are injectable GLP-1 receptor agonists that target these incretin receptors to take advantage of the latter effects to promote weight loss
Safety and Tolerability of GLP-1, Dual, and Triple Agonists in Adolescents While GLP-1RAs and their dual and triple agonist counterparts have shown remarkable efficacy in weight loss and metabolic control, their safety and tolerability profiles remain key concerns, especially in adolescent populations
The road towards triple agonists: glucagon-like peptide 1, glucose-dependent insulinotropic polypeptide and glucagon receptoran update
Healthy Eating FDA update: These supplements contain toxic yellow oleander Supplements
A two-week medication pause is not enough